Keyword Connections

tocilizumab

Journals

7

1 british journal of pharmacology

2 journal of neuroimmunology

3 journal of ophthalmic inflammation and infection

4 international journal of antimicrobial agents

5 cancer treatment and research communications

6 Acute and critical care

7 Techniques in hand & upper extremity surgery

Research Groups

0

No Research Group Connected

Bibliographies

22

1 Interleukin-6 inhibition in the management of non-infectious uveitis and beyond.

2 Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.

3 Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

4 Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.

5 Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS?

6 possibility of complex medicamental and endovascular treatment of pulmonary hypertension in takayasu arteritis with predominant pulmonary arteries’ lesion

7 update and new approaches in the treatment of castleman disease

8 Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study.

9 Omega Plate Fixation of Comminuted Olecranon Fractures: Technique and Case Series.

10 When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and its Cardiovascular Safety.

11 Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review.

12 Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?

13 Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report.

14 A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient.

15 acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis

16 case report: safety and efficacy of tocilizumab in a patient with rheumatoid arthritis and chronic hepatitis c

17 tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions

18 critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis

19 serum proteome analysis in patients with rheumatoid arthritis receiving therapy with tocilizumab: an anti-interleukin-6 receptor antibody

20 spotlight on tocilizumab and its potential in the treatment of systemic sclerosis

21 herpes zoster meningitis complicating combined tocilizumab and cyclosporine therapy for adult-onset still’s disease

22 Tocilizumab ist zur Behandlung des Primären Sjögren Syndroms ungeeignet